Literature DB >> 11083845

Neutralizing antibodies to adenylate cyclase toxin promote phagocytosis of Bordetella pertussis by human neutrophils.

C L Weingart1, P S Mobberley-Schuman, E L Hewlett, M C Gray, A A Weiss.   

Abstract

A previous study showed that opsonization with human immune serum could either promote or antagonize phagocytosis of Bordetella pertussis by human neutrophils depending on whether the bacteria expressed adenylate cyclase toxin. Opsonization of the wild-type strain inhibited phagocytosis relative to unopsonized controls. In contrast, mutants lacking adenylate cyclase toxin were efficiently phagocytosed when opsonized with human immune serum. In this study, we examined opsonization in the presence or absence of monoclonal antibodies to adenylate cyclase toxin. Addition of neutralizing monoclonal antibodies to adenylate cyclase toxin converted a serum that previously inhibited both attachment and phagocytosis of the wild-type strain to one that increased both attachment and phagocytosis compared to the no-serum control. Monoclonal antibodies that recognize the adenylate cyclase toxin but fail to neutralize activity were without effect. These results suggest that adenylate cyclase toxin inhibits both Fc receptor-mediated attachment and phagocytosis of B. pertussis by neutrophils.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083845      PMCID: PMC97830          DOI: 10.1128/IAI.68.12.7152-7155.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  Bordetella pertussis virulence factors affect phagocytosis by human neutrophils.

Authors:  C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

2.  Phagocytosed Bordetella pertussis fails to survive in human neutrophils.

Authors:  D H Lenz; C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Both adenylate cyclase and hemolytic activities are required by Bordetella pertussis to initiate infection.

Authors:  N Khelef; H Sakamoto; N Guiso
Journal:  Microb Pathog       Date:  1992-03       Impact factor: 3.738

4.  Adenylate cyclase toxin is critical for colonization and pertussis toxin is critical for lethal infection by Bordetella pertussis in infant mice.

Authors:  M S Goodwin; A A Weiss
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

5.  Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.

Authors:  A A Weiss; E L Hewlett; G A Myers; S Falkow
Journal:  J Infect Dis       Date:  1984-08       Impact factor: 5.226

6.  Bordetella pertussis adenylate cyclase toxin: intoxication of host cells by bacterial invasion.

Authors:  M Mouallem; Z Farfel; E Hanski
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

7.  Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils.

Authors:  C L Weingart; G Broitman-Maduro; G Dean; S Newman; M Peppler; A A Weiss
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

8.  Phagocyte impotence caused by an invasive bacterial adenylate cyclase.

Authors:  D L Confer; J W Eaton
Journal:  Science       Date:  1982-09-03       Impact factor: 47.728

9.  Extracytoplasmic adenylate cyclase of Bordetella pertussis.

Authors:  E L Hewlett; M A Urban; C R Manclark; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

10.  Placebo-controlled trial of two acellular pertussis vaccines in Sweden--protective efficacy and adverse events. Ad Hoc Group for the Study of Pertussis Vaccines.

Authors: 
Journal:  Lancet       Date:  1988-04-30       Impact factor: 79.321

View more
  31 in total

1.  Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults.

Authors:  C L Weingart; W A Keitel; K M Edwards; A A Weiss
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

2.  Immunoglobulin A-mediated protection against Bordetella pertussis infection.

Authors:  S M Hellwig; A B van Spriel; J F Schellekens; F R Mooi; J G van de Winkel
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Monoclonal antibodies against Vibrio vulnificus RtxA1 elicit protective immunity through distinct mechanisms.

Authors:  Tae Hee Lee; Sun-Shin Cha; Chang-Seop Lee; Joon Haeng Rhee; Kyung Min Chung
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

4.  Influence of CR3 (CD11b/CD18) expression on phagocytosis of Bordetella pertussis by human neutrophils.

Authors:  Paula S Mobberley-Schuman; Alison A Weiss
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

5.  Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction.

Authors:  Fabiana Spensieri; Giorgio Fedele; Cecilia Fazio; Maria Nasso; Paola Stefanelli; Paola Mastrantonio; Clara Maria Ausiello
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

6.  Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Kari Torkildsen Brandsdal; Bjørn Peter Berdal; Erja M Aleksandersen; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2007-05-16

7.  Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity.

Authors:  Audun Aase; Tove Karin Herstad; Samuel Merino; Merete Bolstad; Synne Sandbu; Hilde Bakke; Ingeborg S Aaberge
Journal:  Clin Vaccine Immunol       Date:  2011-06-15

Review 8.  Toxins from bacteria.

Authors:  James S Henkel; Michael R Baldwin; Joseph T Barbieri
Journal:  EXS       Date:  2010

9.  Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

10.  Bordetella adenylate cyclase toxin is a unique ligand of the integrin complement receptor 3.

Authors:  Radim Osicka; Adriana Osickova; Shakir Hasan; Ladislav Bumba; Jiri Cerny; Peter Sebo
Journal:  Elife       Date:  2015-12-09       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.